House passes tax deduction; Device to detect Alzheimer's shows promise;

@FierceMedDev: Massachusetts med tech outfit wins $1M from NIH to develop pediatric stent system. Story | Follow @FierceMedDev

@StacyALawrence: ICYMI last week: FDA clears oral sleep apnea device, as search for CPAP alternatives continues. Story | Follow @StacyALawrence

@VarunSaxena2: FDA panel recommends stronger labeling, limiting use of power morcellation--agency may go farther. Article | Follow @VarunSaxena2

@EmilyWFierce: Global infectious diseases are infiltrating the Times' crossword puzzles. Here's a roundup of clues: More | Follow @EmilyWFierce

> The House of Representatives passed a tax-related bill that increases and makes permanent a "bonus depreciation" deduction of 50%. The bill, which must pass the Senate, was received favorably by AdvaMed due to its potential for American investment and job creation. Release

> Australian researchers shared their preliminary results on a noninvasive optical imaging device that can be used to detect early signs of Alzheimer's. Tomorrow, the researchers will present their findings at the Alzheimer's Association International Conference in Denmark. Story

> Orthocare Innovations' prosthetic foot, Magellan, has joined forces with Vicon's mobile app, Galileo, to monitor and send data on the foot's movement to a doctor-monitored website. The app also gives patients options to adjust their prosthetic to improve mobility and stability. Story

Biotech News

@FierceBiotech: Fresh off Phase III success, Otonomy shoots for an $86M IPO. Story | Follow @FierceBiotech

@JohnCFierce: I'm soon going offline for a week. will be holding down the fort. Please postpone all big news until I get back. :) | Follow @JohnCFierce

@DamianFierce: Via @WSJ, $ABBV + $SHPG would leapfrog $LLY. More (sub. req.) | Follow @DamianFierce

@EmilyMFierce: Like in Humans, Genes Drive Half of Chimp Intelligence, Study Finds via . Article | Follow @EmilyMFierce

> Does crowdfunding work in biotech? Item

> President's advisory group calls for clinical trial changes, incentives for antibiotics R&D. More

> Roche and Exelixis herald a Phase III victory for their melanoma combo. News

> President's advisory group calls for clinical trial changes, incentives for antibiotics R&D. Story

Pharma News

@FiercePharma: Top-read on FP this weekend: Sun issues third recall since announcing deal to buy Ranbaxy. Article | Follow @FiercePharma

@EricPFierce: ICYMI last week: Weak link in the supply chain. Pharmacist walks out of NY hospital with 1,500 oxycodone tabs. Report | Follow @EricPFierce

@CarlyHFierce: ICYMI: Solid PhIII brings Sanofi closer to blockbuster dengue sales. FierceVaccines story | Follow @CarlyHFierce

> Shire finally comes to AbbVie's buyout table, thanks to $53B-plus bid. Story

> Riled by $84,000 Sovaldi, Senate panel digs into Gilead's Pharmasset buy. More

> China indicts PI and his American wife for 'illegal' activities in GSK bribery probe. Report

> Teva's picked its next chairman, rebel investor Landa says--and he's not in favor. News

CRO News

> China's HD Bio teams with Marshall U. for cancer R&D. Article

> CMOs eye Russia for growth. Item

> InVentiv joins a nonprofit effort to make trials more efficient. News

> Risk-sharing CRO Ergomed banks $18.9M and awaits a U.K. IPO. Story

> U.K. CRO emerges from $100M in deals with plans for more M&A. Article

Biotech IT News

> Google creates new cash source for European biotech IT startups with $100M VC fund. News

> Row over IT focus of Europe's brain project prompts 280 scientists to threaten a boycott. Story

> PHT prioritizes Android over Apple in preparation for 'bring your own device' trials. Article

> FDA warns Gilead over 'misleading' paid search link. Item

> After working to mimic the brain for 9 years, Numenta reflects on limitations of today's hardware. Story

Animal Health News

> PEDv diagnostic hits market as vets predict 2.5 million more deaths. Story

> U.K. animal care company profits from generic pet meds. Article

> Industry Voices: How to win at animal health. Report

> Vets may soon be able to carry scheduled drugs. News

> Report: China animal vaccine market up by 26%. Story

Suggested Articles

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.